SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-182090
Filing Date
2021-06-04
Accepted
2021-06-04 07:40:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d181378ddefa14a.htm DEFA14A 23090
  Complete submission text file 0001193125-21-182090.txt   24161
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37620 | Film No.: 21994873
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences